Stark Law

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)

Retrieved on: 
Friday, November 18, 2022
Class Action Lawsuit, Professional Services, Legal, Law, Stark Law, Anti-Kickback Statute, Stark, Remuneration, Exchange, News, U.S. Department of Justice Office of Legislative Affairs, Court, Justice, Suite, Defendant, Genetics, Battle of Saint-Fulgent, Privacy Office of the U.S. Department of Homeland Security

The Law Offices of Frank R. Cruz reminds investors of the upcoming November 21, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) securities between March 22, 2019 and August 4, 2022, inclusive (the Class Period).

Key Points: 
  • The Law Offices of Frank R. Cruz reminds investors of the upcoming November 21, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT ) securities between March 22, 2019 and August 4, 2022, inclusive (the Class Period).
  • If you purchased or otherwise acquired Fulgent securities during the Class Period, you may move the Court no later than November 21, 2022 to request appointment as lead plaintiff in this putative class action lawsuit.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Deadline Alert: Fulgent Genetics, Inc. (FLGT) - Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Class Action Deadlines and Encourages Shareholders to Contact the Firm and Actively Participate

Retrieved on: 
Tuesday, November 15, 2022
Class Action Lawsuit, Professional Services, Legal, Stark Law, Court, Complaint, Person, Genetics, Anti-Kickback Statute, Remuneration, Private investigator, Battle of Saint-Fulgent

Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/flgt .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/flgt .
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.
  • The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Companys business, operations, and compliance policies.
  • Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, November 12, 2022
Disclosure, Federal, Sale, Reward, Complaint, EPS, BCS, Mission statement, ADS, Company, Anti-Kickback Statute, Investment, NASDAQ, Battle of Saint-Fulgent, Annual report, U.S. Department of Defense Strategy for Operating in Cyberspace, IPO, Q2, Federation, GLOBE, Health, U.S. Department of Justice Office of Legislative Affairs, Stark Law, Medicare, War, Patient, SEC, U.S. Securities and Exchange Commission, Prospectus, Government, ADR Institute of Alberta, YSG, News, Remuneration, PLTR, COVID-19, Intelligence, Growth, NYSE, Justice, ADR, Physician, Genetic testing, Security (finance), Animal, Pharmaceutical industry, Audit, Palantir Technologies, Barclays, P.C

The Company has two operating segments, commercial and government,with the latter primarily serving agencies in the U.S. federal government and non-U.S. governments.

Key Points: 
  • The Company has two operating segments, commercial and government,with the latter primarily serving agencies in the U.S. federal government and non-U.S. governments.
  • On May 9, 2022, Palantir issued a press release announcing its Q1 financial results and guidance for Q2.
  • For more information on the Barclays class action go to: https://bespc.com/cases/BCS
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Fulgent Genetics, Inc.

Retrieved on: 
Friday, November 11, 2022
Class Action Lawsuit, Professional Services, Legal, Disclosure, Reward, Stark, Battle of Saint-Fulgent, NASDAQ, Anti-Kickback Statute, Lead, Genetics, Office of Inspector General, U.S. Department of Health and Human Services, Health, U.S. Department of Justice Office of Legislative Affairs, Stark Law, COPY, Medicare, Patient, LLP, SEC, Fraud, News, Remuneration, COVID-19, Insurance, Justice, Physician, Genetic testing, Private investigator, Pharmaceutical industry

The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Fulgent Genetics, Inc. (Fulgent) ( NASDAQ: FLGT ).

Key Points: 
  • The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Fulgent Genetics, Inc. (Fulgent) ( NASDAQ: FLGT ).
  • Kessler Topaz Meltzer & Check, LLP encourages Fulgent investors who have suffered significant losses to contact the firm directly to acquire more information.
  • ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
    Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.

ROSEN, A TOP RANKED LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important November 21 Deadline in Securities Class Action – FLGT

Retrieved on: 
Friday, November 11, 2022
Titan, Federal, Reward, Battle of Saint-Fulgent, NASDAQ, Genetics, Advertising, GLOBE, Health, Class, Anti-Kickback Statute, Medicare, I-Space (Chinese company), Stark Law, Court, Remuneration, Insurance, Tobacco, Pharmaceutical industry

WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

PLTR, FLGT & WBD Class Action Deadlines: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate

Retrieved on: 
Friday, November 11, 2022
Form, U.S. Securities and Exchange Commission, Complaint, Register, EPS, Company, Anti-Kickback Statute, Investment, Battle of Saint-Fulgent, AT&T, Prospectus, Warner Bros., Security (finance), GLOBE, HBO Max, Stark Law, Court, Government, Mergers and acquisitions, LLC, Remuneration, HBO, Growth, Discovery, WarnerMedia

NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.

Key Points: 
  • NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies.
  • You can review a copy of the Complaints by visiting the links belowor you may contact Peretz Bronstein, Esq.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at212-697-6484.
  • If you suffered a loss, you can request that the Court appoint you as lead plaintiff.

Fulgent Genetics’s Investor Alert: Kaplan Fox Reminds Investors of an Important Deadline

Retrieved on: 
Wednesday, November 9, 2022
Genetics, GLOBE, Battle of Saint-Fulgent, Stark Law, FOX, Remuneration, Accusative case, False Claims Act, Justice, Privacy Office of the U.S. Department of Homeland Security, Anti-Kickback Statute, SEC, NASDAQ, Record, News, U.S. Securities and Exchange Commission, Company, Civil investigative demand, U.S. Department of Justice Office of Legislative Affairs, CID, Medical device

NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com ) reminds investors that a securities class action case has been brought against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) and that November 21, 2022 is the deadline for seeking appointment as lead plaintiff.

Key Points: 
  • NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com ) reminds investors that a securities class action case has been brought against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) and that November 21, 2022 is the deadline for seeking appointment as lead plaintiff.
  • WHY CONTACT KAPLAN FOX - Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey.
  • With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand.
  • Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients.

INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That Securities Class Action Lawsuits Have Been Filed on Behalf of Investors in Argo Group International Holdings, Ltd. (ARGO), Fulgent Genetics, Inc. (FLGT), Olo Inc. (OLO), and Encourages Investors t

Retrieved on: 
Tuesday, November 8, 2022
Genetics, GLOBE, Battle of Saint-Fulgent, Remuneration, OLO, Argo, Stark Law, Defendant, Anti-Kickback Statute, Court, Kirby, Argo Group, Online shopping, Private investigator

Additional information about each case can be found at the links provided below.

Key Points: 
  • Additional information about each case can be found at the links provided below.
  • Kirby McInerney is a New York-based plaintiffs law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.
  • The firms efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

DEADLINE ALERT for FLGT, YSG, BCS, OLO: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Tuesday, November 8, 2022
GLOBE, Battle of Saint-Fulgent, Investment, Remuneration, Telephone, Stark Law, Defendant, People's Law Office, Class, Suite, SEC, Anti-Kickback Statute, Time, Barclays, Company, Law, IPO, Security (finance), Public relations

BENSALEM, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith

FULGENT GENETICS, INC. (NASDAQ: FLGT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulgent Genetics, Inc. (NASDAQ: FLGT)

Retrieved on: 
Tuesday, November 8, 2022
Genetics, GLOBE, Battle of Saint-Fulgent, Genetic testing, Health, Investment, Remuneration, Disclosure, Company, Justice, Office of Inspector General, U.S. Department of Health and Human Services, Anti-Kickback Statute, Stark, Stark Law, The Legal 500, SEC, Advertising, NASDAQ, News, Securities Exchange Act of 1934, Reward, District court, U.S. Department of Justice Office of Legislative Affairs, Court, Medicare, Physician, Patient, NEW, Labour government, Central District, COVID-19, Tobacco, Pharmaceutical industry, Security (finance)

NEW YORK, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Central District of California and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Fulgent, together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally.
  • If you purchased Fulgent securities, and/or would like to discuss your legal rights and options please visit Fulgent Genetics, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.